Becker's Hospital Review3h
AI cuts length of stay in half after angioplasty: 5 notes
The use of an AI-powered risk assessment tool cut the average length of stay for patients undergoing cardiac catheterization ...
Frontiers17d
Interpreting clinical outcomes using different strut thickness in coronary artery disease: insights from vascular imaging analysis
Background: Coronary artery disease is a global health concern that necessitates treatments, such as percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Recent advancements in ...
jnis.bmj28d
The River study: the first prospective multicenter trial of a novel venous sinus stent for the treatment of idiopathic intracranial hypertension
Background The River stent is the first stent specifically designed for intracranial ... The primary safety endpoint was met with a rate of major adverse event of 5.4% versus 51.7% for CSF shunts. The ...
Endovascular Today28d
Serenity’s River Venous Sinus Stent Studied to Treat Idiopathic Intracranial Hypertension
According to the company, the trial evaluated the company’s River venous sinus stent for the treatment of idiopathic intracranial hypertension (IIH) in patients who are refractory or intolerant to ...
Frontiers1mon
Case report: Upper gastrointestinal bleeding associated with pancreatic segmental portal hypertension: six case reports and literature review
Simple splenectomy alone could not solve the portal occlusion, so balloon dilation and splenic vein stent implantation (SVS ... elective transjugular intrahepatic portosystemic shunt (TIPS), and liver ...
WPRI 121mon
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures
TOLEDO, Ohio and MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime Carotid Stent System for the prevention of stroke related to carotid ...
jnis.bmj2mon
The safety and effectiveness of the LVIS stent system for the treatment of wide-necked cerebral aneurysms: final results of the pivotal US LVIS trial
Introduction The LVIS stent system (LVIS and LVIS Junior) is a self-expanding, retrievable, microstent system indicated for the treatment of wide-necked cerebral aneurysms (WNAs). The present pivotal ...
birmingham.ac.uk1y
REACT-AVB
To investigate the clinical and cost-effectiveness of early transjugular intrahepatic portosystemic stent-shunt (TIPSS) versus endoscopic plus pharmacological therapy in patients with cirrhosis and ...
ahajournals.org3y
Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension
Parenteral medications will shunt right-to-left into the systemic circulation resulting ... limited only by the access requirement of a 7 French venous sheath for Viabahn stent implantation. A ...